Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
NCT00698906
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
HBV-MPL vaccine
BIOLOGICAL:
Engerix™-B
Sponsor
GlaxoSmithKline